Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA) Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol

Neither candesartan nor metoprolol seemed to be protective for chemo-induced cardiac toxicity (trend in the right direction in the candesartan group)

Read the full article here

Related Articles